News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Depomed, Inc. (JOBS) Sues India’s Lupin Ltd. for Patent Infringement
December 1, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Drug developer Depomed Inc said it filed a lawsuit in a U.S. federal court against India's Lupin Ltd alleging that Lupin's application to market a generic version of Depomed's diabetes drug Glumetza infringed its patents.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Asia
MORE ON THIS TOPIC
Cell therapy
Pfizer launches into autoimmune CAR T with China’s Starna in up to $2.6B deal
November 18, 2026
·
1 min read
·
Annalee Armstrong
China
In China’s shadow, Pfizer CEO calls for AI savings to bolster Big Pharma
November 18, 2026
·
1 min read
·
Annalee Armstrong
Opinion
Emerging biotech hubs step up as innovation economics evolve
November 16, 2026
·
5 min read
·
Jogin Desai
Layoffs
Biopharma layoffs rise YOY in October but sharply trend down for 2026
November 12, 2026
·
6 min read
·
Angela Gabriel